Adverum Biotechnologies Inc - ESG Rating & Company Profile powered by AI
The Disclosure score includes 17 United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Decent Work & Economic Growth' and 'Partnerships for the Goals'. The Sustainability rating for Adverum Biotechnologies Inc represents its transparency towards the United Nations SDGs. Check the bottom of this page for potential risks for Adverum Biotechnologies Inc based on industry, location and marketcap.
Adverum Biotechnologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 8.0, social score of 3.2 and governance score of 4.0.
5.1
Medium ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1737978896147)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
687 | Valbiotis SA | 5.2 | High |
687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
724 | Adverum Biotechnologies Inc | 5.1 | High |
724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
724 | Kinnate Biopharma Inc | 5.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1737978896147)
Frequently Asked Questions
Does Adverum Biotechnologies Inc have an accelerator or VC vehicle to help deliver innovation?
Does Adverum Biotechnologies Inc disclose current and historical energy intensity?
Does Adverum Biotechnologies Inc report the average age of the workforce?
Does Adverum Biotechnologies Inc reference operational or capital allocation in relation to climate change?
Does Adverum Biotechnologies Inc disclose its ethnicity pay gap?
Does Adverum Biotechnologies Inc disclose cybersecurity risks?
Does Adverum Biotechnologies Inc offer flexible work?
Does Adverum Biotechnologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Adverum Biotechnologies Inc disclose the number of employees in R&D functions?
Does Adverum Biotechnologies Inc conduct supply chain audits?
Does Adverum Biotechnologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Adverum Biotechnologies Inc conduct 360 degree staff reviews?
Does Adverum Biotechnologies Inc disclose the individual responsible for D&I?
Does Adverum Biotechnologies Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Adverum Biotechnologies Inc disclose current and / or historical scope 2 emissions?
Does Adverum Biotechnologies Inc disclose water use targets?
Does Adverum Biotechnologies Inc have careers partnerships with academic institutions?
Did Adverum Biotechnologies Inc have a product recall in the last two years?
Does Adverum Biotechnologies Inc disclose incidents of discrimination?
Does Adverum Biotechnologies Inc allow for Work Councils/Collective Agreements to be formed?
Has Adverum Biotechnologies Inc issued a profit warning in the past 24 months?
Does Adverum Biotechnologies Inc disclose parental leave metrics?
Does Adverum Biotechnologies Inc disclose climate scenario or pathway analysis?
Does Adverum Biotechnologies Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Adverum Biotechnologies Inc disclose the pay ratio of women to men?
Does Adverum Biotechnologies Inc support suppliers with sustainability related research and development?
Does Adverum Biotechnologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Adverum Biotechnologies Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Adverum Biotechnologies Inc involved in embryonic stem cell research?
Does Adverum Biotechnologies Inc disclose GHG and Air Emissions intensity?
Does Adverum Biotechnologies Inc disclose its waste policy?
Does Adverum Biotechnologies Inc report according to TCFD requirements?
Does Adverum Biotechnologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Adverum Biotechnologies Inc disclose energy use targets?
Does Adverum Biotechnologies Inc disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Adverum Biotechnologies Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Adverum Biotechnologies Inc
These potential risks are based on the size, segment and geographies of the company.
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.